Intellia Therapeutics, Inc. (NTLA)
13.98
-0.01
(-0.07%)
USD |
NASDAQ |
May 13, 10:25
Intellia Therapeutics Cash from Investing (Quarterly) : 66.31M for March 31, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Recursion Pharmaceuticals, Inc. | -0.338M |
| KalVista Pharmaceuticals, Inc. | -1.188M |
| Beam Therapeutics, Inc. | 25.27M |
| Novavax, Inc. | -28.36M |
| Tango Therapeutics, Inc. | -135.72M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -117.35M |
| Cash from Financing (Quarterly) | 33.57M |
| Free Cash Flow | -363.62M |
| Free Cash Flow Per Share (Quarterly) | -0.991 |
| Free Cash Flow to Equity (Quarterly) | -104.59M |
| Free Cash Flow to Firm (Quarterly) | -117.42M |
| Free Cash Flow Yield | -23.21% |